These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 4598215)
1. Mechanism of synergistic effects of beta-lactam antibiotic combinations on gram-negative bacilli. Farrar WE; Newsome JK Antimicrob Agents Chemother; 1973 Aug; 4(2):109-14. PubMed ID: 4598215 [TBL] [Abstract][Full Text] [Related]
2. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 2. Mechanism of resistance (author's transl)]. Schmid B; Kayser FH Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):384-92. PubMed ID: 779354 [TBL] [Abstract][Full Text] [Related]
3. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae. Ku YH; Chuang YC; Yu WL J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741 [TBL] [Abstract][Full Text] [Related]
4. Diversity of beta-lactamase activity among clinical isolates of gram-negative bacilli. Farrar WE; Newsome JK Am J Clin Pathol; 1976 Apr; 65(4):570-4. PubMed ID: 817594 [TBL] [Abstract][Full Text] [Related]
5. Some properties of Serratia marcescens, Salmonella paratyphi A, and Enterobacter cloacae with non-enzyme-dependent multiple resistance to beta-lactam antibiotics, aminoglycosides, and quinolones. Dang P; Gutmann L; Quentin C; Williamson R; Collatz E Rev Infect Dis; 1988; 10(4):899-904. PubMed ID: 3055181 [TBL] [Abstract][Full Text] [Related]
6. Combinations of clavulanic acid and other beta-lactam antibiotics against strains of Pseudomonas aeruginosa, Serratia marcescens and other bacteria. Rogers DT; Russell AD J Appl Bacteriol; 1980 Aug; 49(1):111-8. PubMed ID: 6776086 [No Abstract] [Full Text] [Related]
7. [Resistance to beta-lactam antibiotics and aminoglycosides in gram negative bacteria. 1. Molecular and genetic characterization of R-factors (author's transl)]. Schmid B; Kayser FH Zentralbl Bakteriol Orig A; 1976 Apr; 234(3):371-83. PubMed ID: 779353 [TBL] [Abstract][Full Text] [Related]
8. Induction of plasmid-mediated AmpC β-lactamase DHA-1 by piperacillin/tazobactam and other β-lactams in Enterobacteriaceae. Akata K; Muratani T; Yatera K; Naito K; Noguchi S; Yamasaki K; Kawanami T; Kido T; Mukae H PLoS One; 2019; 14(7):e0218589. PubMed ID: 31283769 [TBL] [Abstract][Full Text] [Related]
9. Activity of OP0595/β-lactam combinations against Gram-negative bacteria with extended-spectrum, AmpC and carbapenem-hydrolysing β-lactamases. Livermore DM; Mushtaq S; Warner M; Woodford N J Antimicrob Chemother; 2015 Nov; 70(11):3032-41. PubMed ID: 26311835 [TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo properties of BAL30376, a β-lactam and dual beta-lactamase inhibitor combination with enhanced activity against Gram-negative Bacilli that express multiple β-lactamases. Page MG; Dantier C; Desarbre E; Gaucher B; Gebhardt K; Schmitt-Hoffmann A Antimicrob Agents Chemother; 2011 Apr; 55(4):1510-9. PubMed ID: 21245441 [TBL] [Abstract][Full Text] [Related]
11. Association of halogenated isoxazolylpenicillins with penicillinase-sensitive beta-lactam antibiotics. Microbiological evaluation on beta-lactamase-producing Enterobacteriaceae. Ravagnan G; Nicoletti M; Renzini G; Strom R Chemotherapy; 1977; 23(3):159-66. PubMed ID: 837773 [TBL] [Abstract][Full Text] [Related]
12. OP0595, a new diazabicyclooctane: mode of action as a serine β-lactamase inhibitor, antibiotic and β-lactam 'enhancer'. Morinaka A; Tsutsumi Y; Yamada M; Suzuki K; Watanabe T; Abe T; Furuuchi T; Inamura S; Sakamaki Y; Mitsuhashi N; Ida T; Livermore DM J Antimicrob Chemother; 2015 Oct; 70(10):2779-86. PubMed ID: 26089439 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of beta-lactamases by beta-lactam antibiotics. O'Callaghan C; Morris A Antimicrob Agents Chemother; 1972 Dec; 2(6):442-8. PubMed ID: 4670438 [TBL] [Abstract][Full Text] [Related]
14. LY-127935: a novel beta-lactam antibiotic with unusual antibacterial activity. Trager GM; White GW; Zimelis VM; Panwalker AP Antimicrob Agents Chemother; 1979 Sep; 16(3):297-300. PubMed ID: 315753 [TBL] [Abstract][Full Text] [Related]
15. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae. Aktaş Z; Kayacan C; Oncul O Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508 [TBL] [Abstract][Full Text] [Related]
16. Activity of tigecycline alone and in combination with colistin and meropenem against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae strains by time-kill assay. Pournaras S; Vrioni G; Neou E; Dendrinos J; Dimitroulia E; Poulou A; Tsakris A Int J Antimicrob Agents; 2011 Mar; 37(3):244-7. PubMed ID: 21236643 [TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of resistance in Enterobacteriaceae towards beta-lactamase antibiotics]. Susić E Acta Med Croatica; 2004; 58(4):307-12. PubMed ID: 15700687 [TBL] [Abstract][Full Text] [Related]
18. Restoration of antibacterial activity of beta-lactams by epigallocatechin gallate against beta-lactamase-producing species depending on location of beta-lactamase. Zhao WH; Asano N; Hu ZQ; Shimamura T J Pharm Pharmacol; 2003 Jun; 55(6):735-40. PubMed ID: 12841932 [TBL] [Abstract][Full Text] [Related]
19. The emergence of beta-lactam resistance among strains of Enterobacter cloacae and Pseudomonas aeruginosa. Aronoff SC Pediatr Infect Dis J; 1989 Sep; 8(9 Suppl):S100-3; discussion S128-32. PubMed ID: 2510122 [TBL] [Abstract][Full Text] [Related]
20. In vitro synergism of FR-31564, a new phosphonic acid antibiotic. Yokota Y; Murakawa T; Nishida M J Antibiot (Tokyo); 1981 Jul; 34(7):876-83. PubMed ID: 7287590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]